Mutual Funds that own Evotec AG
DWS Deutschland
4,305,777
2.92%
0
1.4%
06/29/2018
Government Pension Fund - Global (The)
3,700,512
2.5%
1,328,755
0.01%
12/31/2017
Concentra
3,207,055
2.17%
0
2.97%
05/31/2018
Vanguard Total International Stock Index Fund
1,854,781
1.26%
28,980
0.01%
07/31/2018
DWS Aktien Strategie Deutschland
1,800,213
1.22%
0
0.94%
06/29/2018
iShares TecDAX (DE)
1,789,819
1.21%
0
3.75%
09/07/2018
DekaFonds CF/TF
1,532,396
1.04%
1,032,756
0.69%
06/29/2018
Principal Investors - Diversified International Fund
1,522,737
1.03%
0
0.32%
06/30/2018
DWS Investa
1,494,978
1.01%
0
0.94%
06/29/2018
Allianz Global Investors Fund - German Equity
1,093,573
0.74%
45,065
2.9%
05/31/2018
| Address |
Manfred Eigen Campus
Hamburg Hamburg 22419
Germany
|
|
Employees
|
- |
| Website |
http://evotec.com |
| Updated |
07/08/2019 |
| Evotec AG engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the EVT Execute and EVT Innovate segments. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmes on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. |
